Literature DB >> 36101737

Imaging manifestations of juvenile hyaline fibromatosis: a case report and literature review.

Jinfen Yu1, Linsheng Wang1, Jing Tian1, Xuewen Yu1, Lixin Sun1.   

Abstract

Objective: Juvenile hyaline fibromatosis (JHF) is an autosomal recessive condition caused by a mutation in capillary morphogenesis gene 2 (CMG2) on chromosome 4q21. JHF is an extremely rare genetic disorder, and fewer than a hundred cases have been reported worldwide. In this case report, the clinical features, histopathological features and imaging manifestations of a case of JHF are presented. We present imaging manifestations of one case of JHF to deepen the radiologist's understanding of this condition. The histopathological feature of JHF is hyaline degeneration involving skeletal muscle. Therefore, the lesion has a slightly high density on CT imaging, iso- or hypointense signal on T 1WI and hypointense signal on T 2WI. The boundary between the lesion and skeletal muscle is unclear.
Methods: An 8-year-old male (Case 1) was examined in our department with a complaint of multiple masses on the head, neck and back in 2021. The boy was the only child of his parents and was delivered at 40 weeks gestation by caesarean section. His parents were non-consanguineous.
Results: JHF displays multiple slowly or rapidly growing subcutaneous nodules. The imaging manifestations can reflect histopathological components, including nodular connective tissue and amorphous, partially calcified hyaline material.
© 2022 The Authors. Published by the British Institute of Radiology.

Entities:  

Year:  2022        PMID: 36101737      PMCID: PMC9461728          DOI: 10.1259/bjrcr.20210167

Source DB:  PubMed          Journal:  BJR Case Rep        ISSN: 2055-7159


Introduction

Juvenile hyaline fibromatosis (JHF) is an autosomal recessive condition caused by a mutation in capillary morphogenesis gene 2 (CMG2) on chromosome 4q21.[1,2] JHF is an extremely rare genetic disorder, and fewer than a hundred cases have been reported worldwide.[3] JHF is characterised clinically by multiple papules, nodules or masses in the head and back; hypertrophy of the gingiva; and flexural contractures of the large joints.[4,5] JHF is an early onset disease that typically appears in the first 4 years of life and often shows its first signs early, even at birth.[4,6] The diagnosis is confirmed by demonstration of hyaline deposition in the lesion.[7,8] From the first report of JHF in 1873 to relevant literature reports in 2020, all of the studies focused on histopathology, gene detection, immunohistochemical analysis, clinical treatment and follow up of JHF, whereas imaging manifestations of JHF were rarely reported.[3-5,7-9] We present imaging manifestations of a case of JHF to deepen the radiologist’s understanding of this condition. The literature on JHF and infantile systemic hyalinosis is also reviewed.

Case report

An 8-year-old boy with multiple masses on the head, neck and back since birth was brought to the ENT Department of Shandong Second Provincial General Hospital. The boy was the only child for his parents and was delivered at 40 weeks gestation by caesarean section. His parents were non-consanguineous. His birth weight was 3.5 kg, and he was 50 cm long. Multiple nodules were present on his head at birth. His parents found multiple nodules on his head, neck and back when he was 2 or 3 months old. All the nodules became larger but grew very slowly. In addition, the nodules have remained painless to date. The boy is very clever, and he gets top marks on his exams. Unfortunately, pre-operative photos of the patient were not available due to various reasons, and only one photo of the patient at the age of 1 was available (Figure 1).
Figure 1.

Left temporal scalp nodules.

Left temporal scalp nodules.

Examination

The boy was referred for head, neck and chest CT and MRI examination, which revealed multiple masses on the head, neck and back, and the bone adjacent to the lesion was hyperplastic. The scan ranged from the crown of the head to the upper abdomen and included all lesions. CT and MRI imaging showed multiple soft tissue masses in the parietal, left frontal and occipital aera, left maxillofacial region, periauricular region, subcutaneous fatty space at the level of the second to fourth cervical vertebral body, fatty space behind C3 to C5 of the cervical spinous process, right back muscle and intercostal muscles. The masses were accompanied by hyperosteosclerosis of the adjacent skull or rib. The masses showed iso- or hypointense signals on T1WI and hypointense signals on T2WI. The masses showed hypointense signal on DWI and the ADC map. The mass gradually strengthened with the prolongation of time after the contrast agent was administered. All masses showed mild hyperdensity with hyperosteosclerosis of adjacent bone on CT (Figures 2 and 3). All lesions were indistinguishable from adjacent muscles, which was consistent with the pathological features. High-power histopathological imaging showed hyaline deposition in the lesion, and it invaded the surrounding skeletal muscle with an ill-defined boundary (Figure 4). No abnormalities were observed in the epigastrium, which was confirmed with abdominal ultrasound. No abnormalities were observed by pelvic cavity ultrasound.
Figure 4.

High-power histopathological imaging showed hyaline deposition in the lesion, and the lesion invaded the surrounding skeletal muscle with an ill-defined boundary (haematoxylin and eosin, ×20).

An 8-year-old male with juvenile hyaline fibromatosis. CT and MR imaging showed multiple subcutaneous lesions on the scalp (A–F). The left temporal and right temporoparietal skull bone had hyperplasia and sclerosis (F). The lesions showed iso- or hypointense signals on T1WI and hypointense signals on T2WI (A–D). The masses showed slightly high density on CT (E). T1WI, T1 weighted imaging; T2WI; T2 weighted imaging, The soft tissue lesion on the right back involved intercostal muscles (A–G). The adjacent rib was thickened (F). No obvious signal change was noted after fat pressing on T1WI (C). The lesion showed hypointense signal on T1WI and hypointense signal on T2WI (A–B). The lesions showed hyperintensity on FS-T1WI after the contrast agent was administered (D). The masses show hypointense signals on DWI and ADC maps (E–F). The mass lesion showed slightly high density on CT (G). ADC, apparent diffusion coefficient; DWI, diffusion-weighted imaging; FS, fat saturated; T1WI, T1 weighted imaging; T2WI; T2 weighted imaging. High-power histopathological imaging showed hyaline deposition in the lesion, and the lesion invaded the surrounding skeletal muscle with an ill-defined boundary (haematoxylin and eosin, ×20).

Discussion

JHF is a rare hereditary disorder first reported as “mollusum fibrosum” in 1873 by Murray.[9] The name “juvenile hyaline fibromatosis” was first introduced by Drescher et al. in 1967.[10] Drescher et al officially named the condition JHF in 1969.[11] JHF is a relatively mild presentation of hyaline fibromatosis syndrome, which is a connective tissue disease with two different clinical manifestations of similar pathophysiology: infantile hyaline fibromatosis (IHF) and JHF. IHF with involvement of the viscera is the most lethal form.[2,12-16] Patients with juvenile hyaluronidosis can survive into adulthood, whereas patients with IHF suffer from intractable diarrhoea and recurrent infections leading to early death.[16] Fortunately, our patient’s viscera were not affected by the lesion. The clinical features of JHF include gingival hyperplasia, osteopaenia, osteolytic bone lesions, papular and nodular skin lesions, and joint contractures.[4,5,16,17] Skin lesions are present at birth or develop in early childhood. The diagnosis is confirmed by demonstration of hyaline deposition in the lesion.[7,8] In our case, high-power histopathological imaging revealed hyaline deposition in the lesion, and the lesion invaded the surrounding skeletal muscle with an ill-defined boundary. Therefore, lesions were indistinguishable from adjacent muscles on CT and MRI imaging. Gene detection reveals a mutation in capillary morphogenesis gene 2 (CMG2) on chromosome 4q21. CMG2 encodes a protein involved in basement membrane matrix assembly, in particular collagen type VI homeostasis, and endothelial cell morphogenesis.[1,2,16,18] Our patient had multiple masses on the head, neck and back, which was a common finding in this condition. The masses were accompanied by hyperosteosclerosis adjacent to the skull or rib. The masses showed iso- or hypointense signals on T1WI and hypointense signals on T2WI. The mass gradually strengthened with time after the contrast agent was administered. All lesions showed slightly high density on CT. We assume that these imaging manifestations are closely related to histopathological findings, namely, nodular connective tissue and amorphous, partially calcified hyaline material.[16,19] Generally, gingival hyperplasia is observed in JHF, and cases without gingival hyperplasia have only rarely been reported.[20] However, no gingival hyperplasia was noted in our case. JHF displays multiple slowly or rapidly growing subcutaneous nodules.[16,20] Our patient presented with a painless swelling mass. The treatment of JHF is generally considered to be unsatisfactory. Recurrence may occur after excision of the mass.[6,16] Gingivectomy is useful for gingival hyperplasia. Frequent periodontal visits are important for maintaining oral hygiene and decreasing the growth rate of gingiva in JHF.[19]

Learning points

First, JHF is characterised clinically by multiple papules, nodules or masses in the head and back; hypertrophy of the gingiva; and flexural contractures of the large joints at birth or in the first 4 years of life. Second, the lesion involves skeletal muscle with an ill-defined boundary. The lesion may or may not involve viscera and gingiva. Finally, hyaline deposition in the lesion results in its characteristic radiographic appearance.
  19 in total

1.  On three peculiar cases of Molluscum Fibrosum in Children in which one or more of the following conditions were observed: hypertrophy of the gums, enlargement of the ends of the fingers and toes, numerous connecive-tissue tumours on the scalp, &c.

Authors:  J Murray
Journal:  Med Chir Trans       Date:  1873

2.  Juvenile hyaline fibromatosis. Case report with five years' follow-up.

Authors:  I Miyake; H Tokumaru; H Sugino; M Tanno; T Yamamoto
Journal:  Am J Dermatopathol       Date:  1995-12       Impact factor: 1.533

3.  Spectrum of mutations in the ANTXR2 (CMG2) gene in infantile systemic hyalinosis and juvenile hyaline fibromatosis.

Authors:  G Y El-Kamah; K Fong; M El-Ruby; H H Afifi; S E Clements; J E Lai-Cheong; K Amr; M El-Darouti; J A McGrath
Journal:  Br J Dermatol       Date:  2010-03-17       Impact factor: 9.302

4.  Periodontal treatment of two siblings with juvenile hyaline fibromatosis.

Authors:  Sema S Hakki; Tamer Ataoglu; Mustafa C Avunduk; Esra Erdemli; Omer Gunhan; Nazneen Rahman
Journal:  J Clin Periodontol       Date:  2005-09       Impact factor: 8.728

5.  Juvenile hyaline fibromatosis and infantile systemic hyalinosis overlap associated with a novel mutation in capillary morphogenesis protein-2 gene.

Authors:  Richard J Antaya; Mariana M Cajaiba; Joseph Madri; Maria A Lopez; Maria Celeste M Ramirez; John A Martignetti; Miguel Reyes-Múgica
Journal:  Am J Dermatopathol       Date:  2007-02       Impact factor: 1.533

6.  Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.

Authors:  Sandra Hanks; Sarah Adams; Jenny Douglas; Laura Arbour; David J Atherton; Sevim Balci; Harald Bode; Mary E Campbell; Murray Feingold; Gökhan Keser; Wim Kleijer; Grazia Mancini; John A McGrath; Francesco Muntoni; Arti Nanda; M Dawn Teare; Matthew Warman; F Michael Pope; Andrea Superti-Furga; P Andrew Futreal; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2003-08-21       Impact factor: 11.025

7.  Juvenile hyaline fibromatosis: an expanded clinicopathologic spectrum.

Authors:  A E Kan; M Rogers
Journal:  Pediatr Dermatol       Date:  1989-06       Impact factor: 1.588

8.  The gene for juvenile hyaline fibromatosis maps to chromosome 4q21.

Authors:  Nazneen Rahman; Melanie Dunstan; M Dawn Teare; Sandra Hanks; Sarah J Edkins; Jaime Hughes; Graham R Bignell; Grazia Mancini; Wim Kleijer; Mary Campbell; Gokhan Keser; Carol Black; Nigel Williams; Laura Arbour; Matthew Warman; Andrea Superti-Furga; P Andrew Futreal; F Michael Pope
Journal:  Am J Hum Genet       Date:  2002-09-04       Impact factor: 11.025

9.  Juvenile hyaline fibromatosis.

Authors:  Z P Shehab; F Raafat; D W Proops
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1995-10       Impact factor: 1.675

10.  Juvenile Hyaline Fibromatosis: Literature Review and a Case Treated With Surgical Excision and Corticosteroid.

Authors:  Omar Braizat; Saif Badran; Atalla Hammouda
Journal:  Cureus       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.